palopegteriparatide
Commercial- Indications
- Hypoparathyroidism
Company intelligence / Profile preview
Specialised Therapeutics
Singapore, Singaporestabiopharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Specialised Therapeutics has successfully commercialized nine specialty products across oncology and other therapeutic areas. The company partners with global pharma/biotech firms to bring late-stage or approved therapies to market in Australia/NZ/SEA. Recent clinical results include a Phase 2 study of oregovomab for ovarian cancer showing improved outcomes when combined with chemotherapy[2].
- Therapeutic areas
- OncologyEndocrinologyRare DiseasesHematologyOtherOphthalmology
- Modalities
- Small moleculesbiologics (including mAbs)specialty drugs
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Akeso Inc., CTTQ-Akeso for anti-PD1 antibody commercializationMember of World Orphan Drug AlliancePartnerships with at least 16 international companies for regional commercialization of their therapies[2][6].
Beyond the preview
Go deeper on Specialised Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Specialised Therapeutics.